Clinical trials
Recruiting Neoplasm Metastasis trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
73 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 2 |
| 2016 | 1 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 11 |
| 2024 | 12 |
| 2025 | 24 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 73 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 9 |
| AstraZeneca | 5 |
| UNICANCER | 5 |
| Gustave Roussy, Cancer Campus, Grand Paris | 4 |
| Centre Leon Berard | 3 |
| Pfizer | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Astellas Pharma Inc | 2 |
| Daiichi Sankyo | 2 |
| Institut Curie | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 73 |
| Breast Neoplasms | 13 |
| Carcinoma, Non-Small-Cell Lung | 12 |
| Colorectal Neoplasms | 11 |
| Neoplasms | 11 |
| Lung Neoplasms | 8 |
| Endometrial Neoplasms | 6 |
| Recurrence | 6 |
| Ovarian Neoplasms | 5 |
| Prostatic Neoplasms | 5 |
Trials
Showing 1 to 25 of 73. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.